CMA Microdialysis AB Release: ISCUS Clinical Microdialysis Analyzer Receives FDA 510(k) Clearance

Published: May 12, 2006

STOCKHOLM & BOSTON 4th May 2006- CMA Microdialysis AB (CMA) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market ISCUS, a portable Microdialysis analyzer, as part of the CMA Cerebral Tissue Monitoring System.

Back to news